614 related articles for article (PubMed ID: 36328466)
1. Electronic nicotine delivery systems (ENDS) flavours and devices used by adults before and after the 2020 US FDA ENDS enforcement priority: findings from the 2018 and 2020 US ITC Smoking and Vaping Surveys.
Gravely S; Meng G; Hammond D; Reid JL; Seo YS; Hyland A; Cummings KM; Rivard C; Fong GT; Kasza KA
Tob Control; 2022 Nov; 31(Suppl 3):s167-s175. PubMed ID: 36328466
[TBL] [Abstract][Full Text] [Related]
2. Impact of the FDA flavour enforcement policy on flavoured electronic cigarette use behaviour changes.
Li D; Ossip DJ; Bansal-Travers M; Xie Z
Tob Control; 2022 Nov; 31(Suppl 3):s176-s183. PubMed ID: 36328457
[TBL] [Abstract][Full Text] [Related]
3. 'Ice' flavoured e-cigarette use among young adults.
Leventhal A; Dai H; Barrington-Trimis J; Sussman S
Tob Control; 2023 Jan; 32(1):114-117. PubMed ID: 34127549
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of disposable pod use and consumer preference for e-cigarette product characteristics among vape shop customers in Southern California: a cross-sectional study.
Galimov A; Leventhal A; Meza L; Unger JB; Huh J; Baezconde-Garbanati L; Sussman SY
BMJ Open; 2021 Oct; 11(10):e049604. PubMed ID: 34610937
[TBL] [Abstract][Full Text] [Related]
5. The Association of E-cigarette Flavors With Satisfaction, Enjoyment, and Trying to Quit or Stay Abstinent From Smoking Among Regular Adult Vapers From Canada and the United States: Findings From the 2018 ITC Four Country Smoking and Vaping Survey.
Gravely S; Cummings KM; Hammond D; Lindblom E; Smith DM; Martin N; Loewen R; Borland R; Hyland A; Thompson ME; Boudreau C; Kasza K; Ouimet J; Quah ACK; O'Connor RJ; Fong GT
Nicotine Tob Res; 2020 Oct; 22(10):1831-1841. PubMed ID: 32449933
[TBL] [Abstract][Full Text] [Related]
6. Flavoured non-cigarette tobacco product use among US adults: 2013-2014.
Bonhomme MG; Holder-Hayes E; Ambrose BK; Tworek C; Feirman SP; King BA; Apelberg BJ
Tob Control; 2016 Nov; 25(Suppl 2):ii4-ii13. PubMed ID: 27794065
[TBL] [Abstract][Full Text] [Related]
7. E-cigarette devices, brands, and flavors attract youth: Informing FDA's policies and priorities to close critical gaps.
Gaiha SM; Lempert LK; McKelvey K; Halpern-Felsher B
Addict Behav; 2022 Mar; 126():107179. PubMed ID: 34861522
[TBL] [Abstract][Full Text] [Related]
8. Flavour spectrum of the Puff family of disposable e-cigarettes.
Ramamurthi D; Chau C; Berke HY; Tolba AM; Yuan L; Kanchan V; Santos G; Jackler RK
Tob Control; 2023 Apr; 32(e1):e71-e77. PubMed ID: 35017264
[TBL] [Abstract][Full Text] [Related]
9. Did JUUL alter the content of menthol pods in response to US FDA flavour enforcement policy?
Yassine A; El Hage R; El-Hellani A; Salman R; Talih S; Eissenberg T; Shihadeh A; Saliba N
Tob Control; 2022 Nov; 31(Suppl 3):s234-s237. PubMed ID: 36328458
[TBL] [Abstract][Full Text] [Related]
10. Examining associations of e-cigarette flavour restrictions with e-cigarette use and success quitting smoking among US adults.
Bold KW; Krishnan-Sarin S; O'Malley S; Morean ME
Tob Control; 2022 Nov; 31(Suppl 3):s184-s186. PubMed ID: 36328465
[TBL] [Abstract][Full Text] [Related]
11. Electronic cigarette users' reactions and responses to a hypothetical ban of flavoured electronic cigarette liquids.
Soule EK; Mayne S; Snipes W; Thomas L; Guy MC; Breland A; Fagan P
Tob Control; 2022 Nov; 31(Suppl 3):s197-s205. PubMed ID: 36328459
[TBL] [Abstract][Full Text] [Related]
12. Menthol e-cigarette sales rise following 2020 FDA guidance.
Diaz MC; Donovan EM; Schillo BA; Vallone D
Tob Control; 2021 Nov; 30(6):700-703. PubMed ID: 32967985
[TBL] [Abstract][Full Text] [Related]
13. Presence of flavoured electronic nicotine delivery system (ENDS) products in US ENDS advertisements, 2015-2020: a content analysis.
Moran MB; Czaplicki L; Tadesse L; Handy J; Welding K; Kelley D; Kennedy RD
BMJ Open; 2023 Jun; 13(6):e070212. PubMed ID: 37385739
[TBL] [Abstract][Full Text] [Related]
14. Trends in unit sales of cooling flavoured e-cigarettes, USA, 2017-2021.
Ali FRM; Seaman EL; Diaz MC; Ajose J; King BA
Tob Control; 2024 Feb; 33(2):147-153. PubMed ID: 35840317
[TBL] [Abstract][Full Text] [Related]
15. Youth patterns of use of electronic nicotine delivery systems (ENDS), Population Assessment of Tobacco and Health (PATH) waves 4-5.5.
Selya A; Shiffman S; Hannon MJ
Addict Behav; 2023 Oct; 145():107783. PubMed ID: 37356317
[TBL] [Abstract][Full Text] [Related]
16. Use of Electronic Nicotine Delivery Systems or Cigarette Smoking After US Food and Drug Administration-Prioritized Enforcement Against Fruit-Flavored Cartridges.
Kasza KA; Rivard C; Seo YS; Reid JL; Gravely S; Fong GT; Hammond D; Hyland A
JAMA Netw Open; 2023 Jun; 6(6):e2321109. PubMed ID: 37389872
[TBL] [Abstract][Full Text] [Related]
17. Young adult e-cigarette use: A latent class analysis of device and flavor use, 2018-2019.
Lanza HI; Leventhal AM; Cho J; Braymiller JL; Krueger EA; McConnell R; Barrington-Trimis JL
Drug Alcohol Depend; 2020 Nov; 216():108258. PubMed ID: 32906038
[TBL] [Abstract][Full Text] [Related]
18. Responses to potential nicotine vaping product flavor restrictions among regular vapers using non-tobacco flavors: Findings from the 2020 ITC Smoking and Vaping Survey in Canada, England and the United States.
Gravely S; Smith DM; Liber AC; Cummings KM; East KA; Hammond D; Hyland A; O'Connor RJ; Kasza KA; Quah ACK; Loewen R; Martin N; Meng G; Ouimet J; Thompson ME; Boudreau C; McNeill A; Sweanor DT; Fong GT
Addict Behav; 2022 Feb; 125():107152. PubMed ID: 34695685
[TBL] [Abstract][Full Text] [Related]
19. How Does the Use of Flavored Nicotine Vaping Products Relate to Progression Toward Quitting Smoking? Findings From the 2016 and 2018 ITC 4CV Surveys.
Li L; Borland R; Cummings KM; Fong GT; Gravely S; Smith DM; Goniewicz ML; O'Connor RJ; Thompson ME; McNeill A
Nicotine Tob Res; 2021 Aug; 23(9):1490-1497. PubMed ID: 33631007
[TBL] [Abstract][Full Text] [Related]
20. Flavour types used by youth and adult tobacco users in wave 2 of the Population Assessment of Tobacco and Health (PATH) Study 2014-2015.
Rose SW; Johnson AL; Glasser AM; Villanti AC; Ambrose BK; Conway K; Cummings KM; Stanton CA; Delnevo C; Wackowski OA; Edwards KC; Feirman SP; Bansal-Travers M; Bernat J; Holder-Hayes E; Green V; Silveira ML; Zhou Y; Abudayyeh H; Hyland A
Tob Control; 2020 Jul; 29(4):432-446. PubMed ID: 31542778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
